The following words and terms, when used in these sections, shall have the following meanings, unless the context clearly indicates otherwise.
- (1) 21-hydroxylase deficiency--An inherited disorder, which if not treated, may lead to serious illness and death.
- (2) Amino acid disorder--An inherited disorder, which if not treated, may cause mental retardation or death.
- (3) Biotinidase deficiency--An inherited disorder, which if not treated, may cause mental retardation, hearing loss, poor muscle control, or death.
(4) Bona fide resident--A person who:
- (A) is physically present within the geographic boundaries of the state;
- (B) has an intent to remain within the state;
- (C) maintains an abode within the state (i.e., house or apartment, not merely a post office box);
- (D) has not come to Texas from another country for the purpose of obtaining medical care, with the intent to return to the person's native country;
(E) does not claim residency in any other state or country; and
- (i) is a minor child residing in Texas whose parent, managing conservator, or guardian is a bona fide resident;
- (ii) is a person residing in Texas who is the legally dependent spouse of a bona fide resident; or
- (iii) is an adult residing in Texas, including an adult whose parent, managing conservator, or guardian is a bona fide resident or who is his/her own guardian.
- (5) Commissioner--The commissioner of the Department of State Health Services or his successor.
- (6) Department--The Department of State Health Services or its successor.
- (7) Diagnostic test--A medical evaluation to confirm results of a screen.
- (8) Fatty acid oxidation disorder--An inherited disorder, which if not treated, may cause mental retardation or death.
- (9) Galactose-1-phosphate uridyltransferase deficiency--An inherited disorder, which if not treated, may cause fatal infection or mental retardation.
- (10) Health care practitioner--A registered nurse recognized as an advanced practice nurse by the Board of Nurse Examiners, a physician assistant licensed by the Texas Physician Assistant Board, or a midwife who has met licensing requirements and standards of the Texas Midwifery Board.
- (11) Heritable disease--An inherited disease that may result in mental or physical retardation or death.
- (12) Hypothyroidism--A disorder, which if not treated, leads to mental and physical retardation.
- (13) Newborn--A child through 30 days of age.
- (14) Newborn screen--One or more tests to identify a newborn who may be at risk of having phenylketonuria, other heritable diseases, or hypothyroidism.
- (15) Organic acidemia--An inherited disorder, which if not treated, may cause mental retardation or death.
- (16) Physician--A person licensed to practice medicine by the Texas Medical Board.
- (17) Provider--The hospital, birthing facility, health care practitioner, midwife, clinic, or laboratory that collects and submits the newborn screen blood specimen.
- (18) Satisfactory specimen--A blood specimen obtained by uniform absorption of capillary blood onto a filter paper target such that the target is completely filled with blood and soaked through from back to front of the paper. The blood specimen must be completely dry before shipping and be submitted with the accurate and fully completed demographic information sheet.
- (19) Screen--One or more tests that identify an increased risk for a disorder, which must be confirmed by diagnostic tests. A screen may produce false positive or false negative results and should not be relied upon as "diagnostic".
- (20) Sickling hemoglobinopathy, including sickle cell anemia, hemoglobin S/C disease, and sickle betathalassemia--An inherited disorder which, if not treated, may cause fatal infection and interrupted blood supply to vital organs.
- (21) Specimen collection form--The specimen collection form consists of a patient demographic information sheet (original and carbonless copy) with an attached filter paper collection device.
- (22) Specimen collection kit--A single department-approved bar-coded, quality controlled filter paper collection device, demographic information sheet, and envelope which may be used to submit a newborn's blood specimen for the first or second screen, repeat or follow-up testing.
Source Note:The provisions of this §37.52 adopted to be effective November 1, 2006, 31 TexReg 8835.